Midatech Pharma Competitors and Similar CompaniesClear all
Midatech Pharma's competitors and similar companies include F-star Biotechnology, Quark Pharmaceuticals, KemPharm and Juno Therapeutics.
 Midatech Pharma Midatech employs its proprietary self-assembling biocompatible nanoparticle technology to develop nanomedicines. |  F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. |  Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. |  Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | |
Founding Date | Founding Date 2000 | Founding Date 2006 | Founding Date 1994 | Founding Date 2006 | Founding Date 2013 |
Type | Type Public | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cardiff, GB HQ Milton, GB | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Newark, US HQ | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US |
Employees | Employees 8414% increase | Employees 39 | Employees 781% decrease | Employees 333% increase | Employees 1091% decrease |
Valuation ($) | Valuation ($) 38.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 200.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) $111.9m (FY, 2017) |
Net income | Net income (£6.4m) (FY, 2025) | Net income (£2.6m) (FY, 2018) | Net income N/A | Net income $83.2m (FY, 2025) | Net income ($437.1m) (FY, 2017) |
Operating ⚠ | |||||
Patent Applications | Patent Applications 81 (Apr, 2017) | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications 481 (FY, 2016) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 9.4m (over 12 years ago) | Latest funding round $ 10m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 57.3m | Total funding raised $ 37m | Total funding raised N/A | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
F-star Biotechnology
HQ
Cambridge, GB
Employees
39
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View companyQuark Pharmaceuticals
HQ
Newark, US
Employees
78↓ 1% decrease
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View companyKemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View companyJuno Therapeutics
HQ
Seattle, US
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company